Camp4 Therapeutics Corp (CAMP) stock forecast and price target
Price $3.80 · data as of November 13, 2026
12-month price target
Average target$10.22
Upside / downside+169.0%
Analysts9
ConsensusStrong buy
Low $6.00Average $10.22High $15.00
Gold marker: average target · white marker: today’s price ($3.80)
Analyst ratings
Strong buy 3Buy 7Hold 0Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-1.21 | +26.8% | $7M |
| Next fiscal year ends December 31, 2027 | $-0.84 | +30.0% | $6M |
| Next quarter ends December 31, 2026 | $-0.19 | +13.7% | $2M |
| Quarter after ends March 31, 2027 | $-0.14 | — | $2M |
Consensus of the analysts covering Camp4 Therapeutics, updated daily. In the last 30 days 0 estimates were raised and 1 lowered.
Frequently asked questions
What is the Camp4 Therapeutics stock price target?
The average 12-month target from 9 analysts is $10.22, 169.0% above the current price of $3.80 Targets range from $6.00 to $15.00.
Is Camp4 Therapeutics a buy according to analysts?
The consensus rating is “Strong buy” (3 strong buy, 7 buy). Ratings are opinions, not guarantees; this is not investment advice.
How much is Camp4 Therapeutics expected to earn?
Analysts expect EPS of $-1.21 for the fiscal year ending December 31, 2026 and $-0.84 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.